Argos Therapeutics, Inc.

Genexine Inc. may be one of the South Korean bioventures most actively engaged in seeking foreign partnerships and acquisitions in the past few years. Most recently, its US joint venture CoImmune Inc

2019 was a challenging year for the South Korean pharma and biotech sector. On balance, negative and disappointing news outnumbered positive developments, amid issues regarding the country’s first app

The South Korean pharma industry has gone through vast changes in the past decade. The sector has shifted its focus more to the development of new drugs and away from generics, increased the developme

As evidenced by the latest announcement from AbbVie Inc. and Allergan PLC , there is still clearly a good appetite for large merger and acquisition deals in the global pharma and biotech space. By